Mountain View, CA
R3 Vascular creates bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease. R3 Vascular's polymer and proprietary technologies are used to create scaffolds that balance strength and flexibility for the treatment of peripheral arterial disease. The magnitude BRS device is the thinnest BRS ever tested in this clinical setting, with a strut thickness of 98 microns across its entire usable range of diameters.
r3vascular.comThese are collections R3 is a part of. Click on the collection name to view similar companies.
Series B
$87,000,000
Series A
$17,800,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on R3.